Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?


Journal

Health literacy research and practice
ISSN: 2474-8307
Titre abrégé: Health Lit Res Pract
Pays: United States
ID NLM: 101712185

Informations de publication

Date de publication:
07 2021
Historique:
entrez: 14 7 2021
pubmed: 15 7 2021
medline: 7 4 2022
Statut: ppublish

Résumé

Assessing health literacy and patient activation at the beginning of care could facilitate the provision of appropriate information to patients with breast cancer and increase the effectiveness of interventions geared toward improving patient involvement in self-managing their health and, consequently, their quality of life. The aim of this study was to evaluate cancer health literacy and patient activation in patients with breast cancer as well as examine their relationships to health-related quality of life (HRQoL) and resource use. Patients with breast cancer positive for human epidermal growth factor receptor 2 (HER2+) receiving care at 12 oncology clinics in Texas were offered participation in the study via convenience sampling. The survey consisted of the 6-item Cancer Health Literacy Tool, the 13-item Patient Activation Measure, the 27-item Functional Assessment of Cancer Therapy - General (version 4), and single-item measures for number of emergency department visits and hospitalizations as well as clinical and demographic characteristics. The mean age of the 146 study participants was 57.1 ± 10.8 years; 92% ( Interventions that aim to improve HRQoL in patients with breast cancer could target modifiable factors like patient activation. The homogeneity of cancer health literacy among study participants might have influenced its nonsignificant relationship with HRQoL and patient activation. Further assessments of health literacy and patient activation in larger and more diverse populations of patients with breast cancer are warranted.

Sections du résumé

BACKGROUND
Assessing health literacy and patient activation at the beginning of care could facilitate the provision of appropriate information to patients with breast cancer and increase the effectiveness of interventions geared toward improving patient involvement in self-managing their health and, consequently, their quality of life.
OBJECTIVE
The aim of this study was to evaluate cancer health literacy and patient activation in patients with breast cancer as well as examine their relationships to health-related quality of life (HRQoL) and resource use.
METHODS
Patients with breast cancer positive for human epidermal growth factor receptor 2 (HER2+) receiving care at 12 oncology clinics in Texas were offered participation in the study via convenience sampling. The survey consisted of the 6-item Cancer Health Literacy Tool, the 13-item Patient Activation Measure, the 27-item Functional Assessment of Cancer Therapy - General (version 4), and single-item measures for number of emergency department visits and hospitalizations as well as clinical and demographic characteristics.
KEY RESULTS
The mean age of the 146 study participants was 57.1 ± 10.8 years; 92% (
CONCLUSIONS
Interventions that aim to improve HRQoL in patients with breast cancer could target modifiable factors like patient activation. The homogeneity of cancer health literacy among study participants might have influenced its nonsignificant relationship with HRQoL and patient activation. Further assessments of health literacy and patient activation in larger and more diverse populations of patients with breast cancer are warranted.

Identifiants

pubmed: 34260317
doi: 10.3928/24748307-20210524-02
pmc: PMC8279019
doi:

Substances chimiques

ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e171-e178

Références

J Gen Intern Med. 2004 Dec;19(12):1228-39
pubmed: 15610334
Breast Cancer Res Treat. 2009 Apr;114(3):403-12
pubmed: 18421576
Patient Educ Couns. 2017 Jul;100(7):1276-1279
pubmed: 28330715
Health Lit Res Pract. 2017 Jul;1(3):e128-e135
pubmed: 29806046
Biomed Res Int. 2018 Jul 3;2018:1452635
pubmed: 30065931
Health Serv Res. 2007 Aug;42(4):1443-63
pubmed: 17610432
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1671-1675
pubmed: 29938464
Soc Sci Med. 2004 Apr;58(7):1309-21
pubmed: 14759678
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Health Qual Life Outcomes. 2007 May 02;5:24
pubmed: 17474993
Am J Emerg Med. 2016 Jan;34(1):93-6
pubmed: 26508580
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
BMC Health Serv Res. 2016 Oct 18;16(1):582
pubmed: 27756341
PLoS One. 2013 Sep 04;8(9):e74373
pubmed: 24023942
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
J Health Commun. 2014;19 Suppl 2:205-24
pubmed: 25315594
Oncol Rev. 2012 Jan 30;6(1):e2
pubmed: 25992204
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Diabetes Res Clin Pract. 2011 Aug;93(2):260-267
pubmed: 21684030
Am J Health Behav. 2007 Sep-Oct;31 Suppl 1:S19-26
pubmed: 17931132
CA Cancer J Clin. 2011 Jan-Feb;61(1):50-62
pubmed: 21205833
J Ambul Care Manage. 2007 Jan-Mar;30(1):21-9
pubmed: 17170635
Patient Educ Couns. 2014 Mar;94(3):432-7
pubmed: 24331277

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH